The MarketReader Minute
💊 Scholar Rock Dips Amid Upsized $300M Offering, Gilead Rises with Promising New Data and Arcus Gains on Upcoming Oncology Data | Biotech Sector Insights
Among the ETF's holdings, notable contributors to performance include BNTX, SRPT, HALO, MDGL, and MRNA, all of which experienced declines. Additionally, the iShares iBoxx $ High Yield Corporate Bond ETF (HYG) has decreased, reflecting broader market sentiment that may also influence the IBB.